BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7341421)

  • 1. Correlation of cytology with histopathology and cystoscopy in urinary bladder tumours.
    Javali D; Singh SM; Gupta NP; Wadhwa SN
    Indian J Cancer; 1981 Dec; 18(4):241-4. PubMed ID: 7341421
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystoscopy of chemically induced bladder neoplasms in rabbits administered the carcinogen dibutylnitrosamine.
    Cohen AE; Weisburger EK; Weisburger JH; Ward JM; Putnam CL
    Invest Urol; 1975 Jan; 12(4):262-6. PubMed ID: 1112656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
    Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Feb; 16(2):192-5. PubMed ID: 19054166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma-in-situ of the urinary bladder--histological and cytological observations.
    Schade RO
    Proc R Soc Med; 1967 Feb; 60(2):109-11. PubMed ID: 6018822
    [No Abstract]   [Full Text] [Related]  

  • 9. In-situ carcinoma of the urinary bladder.
    Kulatilake AE; Chisholm GD; Olsen EG
    Proc R Soc Med; 1970 Jan; 63(1):95-7. PubMed ID: 5417795
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of urinary cytology for detection of bladder cancer.
    Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A
    Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive bladder carcinoma in childhood: review of the literature apropos of 2 unusual cases].
    Arap S; Wroclawski ER; Abrão EG; Queiroz e Silva FA; de Góes GM
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Oct; 36(5):202-5. PubMed ID: 7339838
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of endoscopic biopsy in bladder tumors].
    Ondrus B; Hornák M; Zvara V
    Z Urol Nephrol; 1968 Dec; 61(12):843-52. PubMed ID: 5731196
    [No Abstract]   [Full Text] [Related]  

  • 15. Cystoscopy in cases of carcinoma of the cervix uteri: clinical experience with 85 cases.
    Dhall R; das de SK
    J Indian Med Assoc; 1995 Sep; 93(9):344-5. PubMed ID: 8648155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.
    Lotan Y; Roehrborn CG
    J Urol; 2002 Jan; 167(1):75-9. PubMed ID: 11743279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of the uCyt+ test for the detection and followup of bladder tumors].
    Drapier E; Renaudin K; Maillet F; Braud G; Laboisse C; Bouchot O
    Prog Urol; 2003 Apr; 13(2):222-6. PubMed ID: 12765055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor.
    Casella R; Huber P; Blöchlinger A; Stoffel F; Dalquen P; Gasser TC; Lehmann K
    J Urol; 2000 Dec; 164(6):1926-8. PubMed ID: 11061883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary cytology of transitional-cell carcinoma].
    Piazza G; Galia A; Cosentino A; Grasso G
    Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.